3-aminocyclopentane-1-carboxylic acid has been researched along with gaboxadol in 1 studies
| Studies (3-aminocyclopentane-1-carboxylic acid) | Trials (3-aminocyclopentane-1-carboxylic acid) | Recent Studies (post-2010) (3-aminocyclopentane-1-carboxylic acid) | Studies (gaboxadol) | Trials (gaboxadol) | Recent Studies (post-2010) (gaboxadol) |
|---|---|---|---|---|---|
| 10 | 0 | 0 | 506 | 34 | 118 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnston, GA | 1 |
1 review(s) available for 3-aminocyclopentane-1-carboxylic acid and gaboxadol
| Article | Year |
|---|---|
GABAA agonists as targets for drug development.
Topics: Acetates; Acrylates; Amines; Analgesics; Anthelmintics; Anticonvulsants; Bicuculline; Computer Simulation; Cyclohexanecarboxylic Acids; Cyclopentanes; Drug Design; Gabapentin; gamma-Aminobutyric Acid; Isoxazoles; Molecular Conformation; Molecular Weight; Receptors, GABA-A | 1992 |